Combining traditional chinese medicine with standard care may ease RA and depression

NCT ID NCT06791980

Completed Knowledge-focused Sponsor: Dalin Tzu Chi General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at whether adding an integrated care model—including traditional Chinese medicine—to standard treatment could lower inflammation and depressive symptoms in people with rheumatoid arthritis. Researchers measured blood markers of inflammation and used a self-reported depression scale in 67 participants over age 20. The goal was to see if this combined approach offers long-term benefits for both body and mind.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: integrated case management model involving traditional Chinese medicine (CM-TCM)
What this could lead to: If successful, this could point toward a way to reduce both inflammation and depression in people with rheumatoid arthritis using a combined care approach.
What could go wrong: This is a small, completed observational study (67 participants) with no control group randomization, so results may not be generalizable. It also relies on self-reported depression scales.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATOID ARTHRITIS (RA)

Contacts and locations

Locations

Dalin Tzuchi Hospital

Chiayi City, 62247, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.